ReviewJournal of clinical medicine2020

Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes.

Angelo Maria Patti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.